• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺样囊性癌的治疗结果:一项14年的分析。

Outcomes in Adenoid Cystic Carcinoma: A 14-Year Analysis.

作者信息

Bin Sumaida Abdulrahman, Shanbhag Nandan M, AlKaabi Khalifa, Hasnain Syed Mansoor, Balaraj Khalid

机构信息

Oncology: Radiation Oncology, Tawam Hospital, Al Ain, ARE.

Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, ARE.

出版信息

Cureus. 2024 Dec 6;16(12):e75222. doi: 10.7759/cureus.75222. eCollection 2024 Dec.

DOI:10.7759/cureus.75222
PMID:39759714
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11700538/
Abstract

Background Adenoid cystic carcinoma (ACC) is a rare malignancy characterized by slow progression, local recurrence, and distant metastases. This study aims to evaluate the demographic patterns, clinical presentations, outcomes, and survival trends of patients with ACC. Methods A retrospective analysis of 14 patients diagnosed with ACC from 2010 to 2024 at a tertiary cancer center in the United Arab Emirates was conducted. Data on demographics, presenting symptoms, clinical outcomes, tumor characteristics, recurrence patterns, and survival were analyzed. Kaplan-Meier survival analysis was performed to evaluate survival trends. Results The cohort was predominantly male (64.3%, n=9) with a mean age of 38.9 years. An enlarging mass in the neck (50%, n=7) was the most common presenting symptom. Local recurrence and distant metastases were observed in 42.9% (n=6) of patients each, with the lungs being the most frequent site of metastases (83.3%, n=5). Advanced-stage disease (Stage III/IV) was common (64.3%, n=9). Overall survival was 85.7% (n=12) over a mean follow-up of 4.3 years. Smoking was associated with poorer survival trends, though not statistically significant (HR=7.0, p=0.083). Conclusion ACC predominantly affects middle-aged individuals and is associated with high rates of local recurrence and distant metastases, especially to the lungs. Although survival trends varied by gender, smoking, and metastases, these differences were not statistically significant, underscoring the need for larger studies to better elucidate prognostic factors.

摘要

背景

腺样囊性癌(ACC)是一种罕见的恶性肿瘤,其特征为进展缓慢、局部复发和远处转移。本研究旨在评估ACC患者的人口统计学模式、临床表现、治疗结果和生存趋势。方法:对2010年至2024年在阿拉伯联合酋长国一家三级癌症中心确诊为ACC的14例患者进行回顾性分析。分析了人口统计学、症状表现、临床结果、肿瘤特征、复发模式和生存数据。采用Kaplan-Meier生存分析评估生存趋势。结果:该队列以男性为主(64.3%,n = 9),平均年龄38.9岁。颈部肿块增大(50%,n = 7)是最常见的症状表现。42.9%(n = 6)的患者出现局部复发和远处转移,肺是最常见的转移部位(83.3%,n = 5)。晚期疾病(III/IV期)常见(64.3%,n = 9)。平均随访4.3年,总生存率为85.7%(n = 12)。吸烟与较差的生存趋势相关,但无统计学意义(HR = 7.0,p = 0.083)。结论:ACC主要影响中年个体,且局部复发和远处转移率高,尤其是肺转移。尽管生存趋势因性别、吸烟和转移情况而异,但这些差异无统计学意义,这突出表明需要进行更大规模的研究以更好地阐明预后因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc15/11700538/f4b3585607b4/cureus-0016-00000075222-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc15/11700538/e5db11cbd128/cureus-0016-00000075222-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc15/11700538/3d21b83c69ab/cureus-0016-00000075222-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc15/11700538/f4b3585607b4/cureus-0016-00000075222-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc15/11700538/e5db11cbd128/cureus-0016-00000075222-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc15/11700538/3d21b83c69ab/cureus-0016-00000075222-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc15/11700538/f4b3585607b4/cureus-0016-00000075222-i03.jpg

相似文献

1
Outcomes in Adenoid Cystic Carcinoma: A 14-Year Analysis.腺样囊性癌的治疗结果:一项14年的分析。
Cureus. 2024 Dec 6;16(12):e75222. doi: 10.7759/cureus.75222. eCollection 2024 Dec.
2
Adenoid cystic carcinoma of the head and neck: a single-center analysis of 105 consecutive cases over a 30-year period.头颈部腺样囊性癌:30 年单中心 105 例连续病例分析。
Oral Oncol. 2013 Aug;49(8):824-9. doi: 10.1016/j.oraloncology.2013.05.004. Epub 2013 Jun 14.
3
Differences in patterns of survival in metastatic adenoid cystic carcinoma of the head and neck.头颈部转移性腺样囊性癌生存模式的差异。
Head Neck. 2017 Mar;39(3):456-463. doi: 10.1002/hed.24613. Epub 2016 Oct 24.
4
Higher positive lymph node ratio indicates poorer distant metastasis-free survival in adenoid cystic carcinoma patients with nodal involvement.在有淋巴结受累的腺样囊性癌患者中,较高的阳性淋巴结比例表明无远处转移生存期较差。
J Craniomaxillofac Surg. 2015 Jul;43(6):751-7. doi: 10.1016/j.jcms.2015.03.040. Epub 2015 Apr 11.
5
Lung metastasis resection of adenoid cystic carcinoma of salivary glands.涎腺腺样囊性癌肺转移瘤切除术
Eur J Cardiothorac Surg. 2008 May;33(5):790-3. doi: 10.1016/j.ejcts.2007.12.057. Epub 2008 Mar 14.
6
Analysis of failure in patients with adenoid cystic carcinoma of the head and neck. An international collaborative study.头颈部腺样囊性癌患者失败情况分析。一项国际合作研究。
Head Neck. 2014 Jul;36(7):998-1004. doi: 10.1002/hed.23405. Epub 2013 Oct 26.
7
Survival Outcomes in Adenoid Cystic Carcinoma of the Head and Neck: A Systematic Review of 17 497 Cases and Meta-Analysis.头颈部腺样囊性癌的生存结局:17497例病例的系统评价与荟萃分析
Head Neck. 2025 May;47(5):1541-1553. doi: 10.1002/hed.28132. Epub 2025 Mar 18.
8
Incidence of adenoid cystic carcinoma in nova scotia: 30-year population-based epidemiologic study.新斯科舍省腺样囊性癌的发病率:一项基于30年人群的流行病学研究。
J Otolaryngol Head Neck Surg. 2008 Oct;37(5):642-8.
9
[Prognostic analysis of 76 cases with adenoid cystic carcinoma in salivary gland].[76例涎腺腺样囊性癌的预后分析]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2012 Mar;47(3):202-6.
10
Cavernous sinus involvement is not a risk factor for the primary tumor site treatment outcome of Sinonasal adenoid cystic carcinoma.海绵窦受累不是影响鼻窦腺样囊性癌原发肿瘤部位治疗效果的危险因素。
J Otolaryngol Head Neck Surg. 2018 Feb 5;47(1):12. doi: 10.1186/s40463-018-0257-z.

本文引用的文献

1
Surgical management of patients with distant metastasized adenoid cystic carcinoma of the head and neck.头颈部远处转移腺样囊性癌患者的外科治疗。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2024 Sep;138(3):362-366. doi: 10.1016/j.oooo.2024.05.004. Epub 2024 May 13.
2
Approaches to the Management of Metastatic Adenoid Cystic Carcinoma.转移性腺样囊性癌的管理方法
Cancers (Basel). 2022 Nov 20;14(22):5698. doi: 10.3390/cancers14225698.
3
Current opinions on diagnosis and treatment of adenoid cystic carcinoma.当前对腺样囊性癌的诊断和治疗的看法。
Oral Oncol. 2022 Jul;130:105945. doi: 10.1016/j.oraloncology.2022.105945. Epub 2022 Jun 2.
4
The Immune Landscape of Chinese Head and Neck Adenoid Cystic Carcinoma and Clinical Implication.中国头颈部腺样囊性癌的免疫景观及其临床意义。
Front Immunol. 2021 Sep 6;12:618367. doi: 10.3389/fimmu.2021.618367. eCollection 2021.
5
Adenoid cystic carcinoma. An indolent but aggressive tumour. Part A: from aetiopathogenesis to diagnosis.腺样囊性癌。一种生长缓慢但具有侵袭性的肿瘤。A部分:从病因发病机制到诊断。
Acta Otorhinolaryngol Ital. 2021 Jun;41(3):206-214. doi: 10.14639/0392-100X-N1379.
6
Management of adenoid cystic carcinoma of the head and neck: a single-institute study with over 25-year follow-up.头颈部腺样囊性癌的治疗:单中心研究及超过 25 年随访。
Head Face Med. 2020 Jul 2;16(1):14. doi: 10.1186/s13005-020-00226-2.
7
Current thinking in the management of adenoid cystic carcinoma of the head and neck.头颈部腺样囊性癌治疗的当前思路。
Br J Oral Maxillofac Surg. 2019 Oct;57(8):716-721. doi: 10.1016/j.bjoms.2019.07.021. Epub 2019 Aug 14.
8
Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma.仑伐替尼治疗进展性、复发性或转移性腺样囊性癌患者的 II 期研究。
J Clin Oncol. 2019 Jun 20;37(18):1529-1537. doi: 10.1200/JCO.18.01859. Epub 2019 Apr 2.
9
A Rare Case of Unresectable Adenoid Cystic Carcinoma of the Nasopharynx Treated with Intensity Modulated Proton Therapy.1例应用调强质子治疗的不可切除性鼻咽腺样囊性癌罕见病例
Cureus. 2017 Sep 15;9(9):e1688. doi: 10.7759/cureus.1688.
10
A phase 2 study of vorinostat in locally advanced, recurrent, or metastatic adenoid cystic carcinoma.伏立诺他用于局部晚期、复发性或转移性腺样囊性癌的2期研究。
Oncotarget. 2017 May 16;8(20):32918-32929. doi: 10.18632/oncotarget.16464.